Form4insider filings, from the source

Insider holders · CIK 0001625288

NEXIEN BIOPHARMA, INC. · NXEN

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Richard S GreenbergEVP and Chairman888,00024,000,00024,888,000Oct 29, 2018 · 3:04 pm EDTForm 4
Intiva USA Inc10% Owner24,000,000—24,000,000Nov 30, 2017 · 2:55 pm ESTForm 4
Ivo HeidenCEO and Chairman10,000,000—10,000,000Sep 6, 2016 · 12:29 pm EDTForm 3/A
Alexander Michael WasylChief Executive Officer5,445,000—5,445,000Nov 1, 2018 · 4:22 pm EDTForm 3
Frank J ManganellaVP Corporate Development2,420,000—2,420,000Nov 8, 2018 · 3:29 pm ESTForm 3
Alain D BankierExecutive Chairman2,256,000—2,256,000Oct 29, 2018 · 6:35 pm EDTForm 4
Jeremy Robert ReehVP Translational Research1,925,000—1,925,000Nov 2, 2018 · 5:18 pm EDTForm 3
Jeffrey Friedlandrelationship not stated833,333228,8001,062,133Jul 25, 2018 · 6:51 pm EDTForm 4/A
Joseph F AcetoVP Legal & IP Counsel1,045,000—1,045,000Oct 31, 2018 · 5:19 pm EDTForm 3
Robert I GoldfarbChief Operating Officer1,028,800—1,028,800Sep 4, 2018 · 4:48 pm EDTForm 4
Evan L WasoffChief Financial Officer1,000,000—1,000,000Oct 30, 2018 · 1:59 pm EDTForm 4
Lindy SniderDirector480,000—480,000Sep 4, 2018 · 5:04 pm EDTForm 4
Courtney Lynne ClarkDirector0—0Aug 17, 2018 · 11:06 am EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.